News for Revance Therapeutics Stock (RVNC)

Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Revance Therapeutics, Inc. of Securities Class Action Lawsuit and Urges Investors with Significant Losses to Contact the Firm

Newsfile Corp • 12/21/21

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Revance Therapeutics, Inc. (RVNC)

Business Wire • 12/21/21

RVNC Investor Alert: Thornton Law Firm Alerts Revance Therapeutics Investors of Class Action Lawsuit

Newsfile Corp • 12/21/21

RVNC Shareholders: Robbins LLP Reminds Investors of Class Action Against Revance Therapeutics, Inc. (RVNC)

Business Wire • 12/21/21

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Revance Therapeutics, Inc. (RVNC)

Business Wire • 12/20/21

RVNC ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Revance Therapeutics, Inc.

Newsfile Corp • 12/18/21

RVNC ALERT: Robbins Geller Rudman & Dowd LLP Announces that Revance Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Newsfile Corp • 12/18/21

Kessler Topaz Meltzer & Check, LLP: Reminds Investors of Securities Fraud Class Action Filed Against Revance Therapeutics, Inc.

Business Wire • 12/17/21

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Revance Therapeutics, Inc. Investors to Secure Counsel Before Important February 8 Deadline in Securities Class Action – RVNC

Business Wire • 12/17/21

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Revance Therapeutics, Inc. (RVNC) Investors

Business Wire • 12/16/21

RVNC INVESTOR FRAUD: Hagens Berman, National Trial Attorneys, Encourages Revance Therapeutics (RVNC) Investors with Significant Losses to Contact Firm's Attorneys, Securities Fraud Class Action Filed

Newsfile Corp • 12/16/21

Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Revance Therapeutics, Inc. (RVNC)

PRNewsWire • 12/16/21

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Revance Therapeutics, Inc. (RVNC) Investors

Business Wire • 12/15/21

RVNC SHAREHOLDERS: Robbins LLP Informs Investors of Class Action Against Revance Therapeutics, Inc. (RVNC)

Business Wire • 12/15/21

DEADLINE: Revance Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RVNC

PRNewsWire • 12/15/21

ROSEN, A LONGSTANDING LAW FIRM, Encourages Revance Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - RVNC

PRNewsWire • 12/14/21

RVNC SECURITIES FRAUD: Hagens Berman, National Trial Attorneys, Encourages Revance Therapeutics (RVNC) Investors with Significant Losses to Contact Firm's Attorneys, Securities Fraud Class Action Filed

PRNewsWire • 12/14/21

REVANCE ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Revance Therapeutics, Inc. and Encourages Investors to Contact the Firm

Business Wire • 12/14/21

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Revance Therapeutics, Inc. a Class Action Lawsuit and a Lead Plaintiff Deadline of February 8, 2022 - RVNC

PRNewsWire • 12/14/21

ALERT: Revance Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RVNC

Business Wire • 12/14/21

EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Revance Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – RVNC

Business Wire • 12/13/21

Revance Therapeutics Investor Alert

Newsfile Corp • 12/12/21

REVANCE THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Revance Therapeutics, Inc. - RVNC

PRNewsWire • 12/12/21

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Revance Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

Newsfile Corp • 12/04/21

ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Revance Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

PRNewsWire • 11/26/21